Market News Today — AI-Curated Stock & Crypto Headlines

Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb

Oil is falling as U.S.-Iran peace talks are back on. Plus, a potential massive merger in the pharmaceutical industry.

Investing.com - U.S. stock index futures advanced on Monday after President Donald Trump said negotiations with Iran were set to …

Trump Pushes for New Iran Negotiations DOJ Ends Controversial Anti-Weaponization Fund Senate Unveils Short-Term Funding Bill Chip Stocks in Focus …

The merger would be one of the biggest pharma deals ever. AstraZeneca’s market capitalization stood at $264 billion as of …

The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.

AstraZeneca has explored an acquisition of Bristol Myers Squibb, according to people familiar with the matter. It’s unclear if discussions …

AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the …

AstraZeneca is in talks with Bristol Myers Squibb for a potential pharma megadeal, which could create one of the world's largest drugmakers.

MPS chief executive weighs approach to Banco BPM’s largest shareholder, Crédit Agricole

The European Union is rewriting its merger rules for the first time in two decades, hoping to create business “champions” …

This week, Harvard professor and former Obama economic adviser Jason Furman discusses the Fed rate decision and the challenges facing …